Rubicon Research

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
1,839.65
-21.5 (-1.16%)
BSENSE

Sep 09, 12:00 PM

BSE+NSE Vol: 93.26 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Rubicon Research
Neuland Labs.
Granules India
Caplin Point Lab
Wockhardt
Emcure Pharma
Sai Life
Acutaas Chemical
ERIS Lifescience
Pfizer
Piramal Pharma

Why is Rubicon Research Ltd ?

1
Low Debt Company with Strong Long Term Fundamental Strength
  • The company is Net-Debt Free
2
With a growth in Net Profit of 17.75%, the company declared Outstanding results in Jun 26
  • The company has declared positive results for the last 2 consecutive quarters
  • OPERATING PROFIT TO INTEREST(Q) Highest at 13.90 times
  • NET SALES(Q) Highest at Rs 534.34 cr
  • PBDIT(Q) Highest at Rs 129.12 cr.
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Rubicon Research should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.10
Debt to EBITDA (avg)
1.50
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.16
Tax Ratio
23.02%
Dividend Payout Ratio
0.23%
Pledged Shares
0
Institutional Holding
16.95%
ROCE (avg)
25.58%
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
107
Industry P/E
37
Price to Book Value
23.90
EV to EBIT
86.69
EV to EBITDA
76.89
EV to Capital Employed
24.54
EV to Sales
17.54
PEG Ratio
NA
Dividend Yield
0.08%
ROCE (Latest)
28.31%
ROE (Latest)
19.14%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Bullish
No Trend
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

32What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 13.90 times

NET SALES(Q)

Highest at Rs 534.34 cr

PBDIT(Q)

Highest at Rs 129.12 cr.

PBT LESS OI(Q)

Highest at Rs 104.69 cr.

PAT(Q)

Highest at Rs 84.78 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 24.16%

EPS(Q)

Highest at Rs 5.13

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Rubicon Research

Operating Profit to Interest - Quarterly
Highest at 13.90 times and Grown
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales - Quarterly
Highest at Rs 534.34 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 129.12 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 104.69 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 84.78 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 534.34 cr has Grown at 21.9% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 438.49 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 24.16%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 104.69 cr has Grown at 33.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 78.21 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 84.78 cr has Grown at 37.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 61.69 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 5.13
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Rubicon Research

Non Operating Income - Quarterly
Highest at Rs 5.68 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income